Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIP: Mucosal Immunity for HIV Prevention
NCT02333045Terminated
- Sponsor
- Emory University
- Start
- Jan 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Emory University. Primary endpoint: Count of Total Cells Obtained From Cervicovaginal Lavage Samples at Day 21. Started Jan 2015; status: terminated.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02333045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333045.